Erin Lawson ● Miroslav “Misha” Backonja
Editors

2013

A Comprehensive Guide for Clinicians

In 2011, the World Health Organization reported that 346 million people worldwide had diabetes [1]. With international rates of diabetes rising (worldwide prevalence of diabetes is estimated to nearly double from 2000 to 4.4 % in 2030),complications including PDN are becoming increasingly prevalent [2]. It is estimated that over 16 % of diabetic patients [3] and approximately 50 % with diabetic neuropathy [4] suffer from painful diabetic neuropathy. Sadly, 40 % of these patients are untreated [3].